Cargando…
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
BACKGROUND: Secondary spontaneous pneumothorax (SSP) in interstitial lung disease (ILD) may influence prognosis of any ILD, and SSP onset predicts poor outcome in idiopathic pulmonary fibrosis (IPF). Recently, progressive fibrosing ILD (PF-ILD) has rapidly acquired importance. OBJECTIVE: We hypothes...
Autores principales: | Yamakawa, Hideaki, Tsukahara, Yuta, Sato, Shintaro, Ohta, Hiroki, Kida, Gen, Nakamura, Tomohiko, Nishizawa, Tomotaka, Kawabe, Rie, Oba, Tomohiro, Akasaka, Keiichi, Amano, Masako, Kuwano, Kazuyoshi, Sasaki, Hiroki, Takemura, Tamiko, Matsushima, Hidekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787380/ https://www.ncbi.nlm.nih.gov/pubmed/35115749 http://dx.doi.org/10.36141/svdld.v38i4.11465 |
Ejemplares similares
-
Patient background and prognosis of chronic pulmonary aspergillosis in fibrosing interstitial lung disease
por: Yamakawa, Hideaki, et al.
Publicado: (2022) -
Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA
por: Yamakawa, Hideaki, et al.
Publicado: (2021) -
The Usefulness of a Transbronchial Lung Cryobiopsy for Diffuse Bronchiolitis
por: Yamakawa, Hideaki, et al.
Publicado: (2020) -
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
por: Yamakawa, Hideaki, et al.
Publicado: (2023) -
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report
por: Yamakawa, Hideaki, et al.
Publicado: (2019)